The JAL Group has participated in the Pink Ribbon Breast Cancer Campaign since 2004. Breast cancer is one of the most common cancers diagnosed in women, and someone in the world is diagnosed with breast cancer every 15 seconds.However, breast cancer is also known that when diagnosed and treated at an early stage, the possibility of being cured increases. Monthly self-examination and annual examination by a physician is recommended.
October which is set to be the "Breast Cancer Awareness Month", the JAL Group has supported the Pink Ribbon activities every year through operating the "Pink Ribbon Flight" where all the cabin attendants on this flight wear pink scarfs to focus attention on breast health, and through special in-flight sales of Pink Ribbon collaborated items on JAL Group domestic routes.
We ask for support through Charity Mile, to JMB members who agree to the intent of the Pink Ribbon Breast Cancer Campaign to support spreading breast cancer awareness and Breast Cancer research.
September 2, 2019 (Monday) 10:00 a.m. (Japan Time) - October 31, 2019 (Thursday) 11:59 p.m. (Japan Time)
Donations will be accepted in units of 3,000 miles on the JAL website.
If you wish to support this Charity with your JMB miles, please click the "Apply" button of your preferred units (mileage).
If you are not logged in, the login screen will appear when you click the "Apply" button. Please log in to your account to apply.
Please check your mileage balance and apply within the mileage available to you.
Please note that applications cannot be cancelled under any circumstances.
Mileage will be deducted within a week of the application date.
JBCRG(Japan Breast Cancer Research Group)
JBCRG (Japan Breast Cancer Research Group)" is a non-profitable organization established in 2007, which plans and manages investigator-initiated clinical trials and treatments for breast cancer. For the sake of breast cancer patients and the society, JBCRG is developing more effective treatments with fewer side effects, and is conducting researches so as to be able to suggest a wider range of options to patients, with breast cancer specialists throughout Japan.